Showing results (221-230 of 631) with videos related to
Sort By:
Pageof 64
Cardiovascular Research|February 26, 2000
Gene therapy in the cardiovascular system: an updateP Sinnaeve, O Varenne, D Collen, et al.Thrombosis and Haemostasis|March 1, 1995
Interactions of staphylokinase with human plateletsH R Lijnen, B Van Hoef, D CollenThrombosis and Haemostasis|April 30, 1984
Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasmaH R Lijnen, B Van Hoef, D CollenEuropean Journal of Biochemistry|December 1, 1987
Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombinH R Lijnen, B Van Hoef, D CollenThe Journal of Biological Chemistry|August 10, 1975
Primary structure of human fibrinogen and fibrin. Isolation and partial characterization of chains of fragment DD Collen, B Kudryk, B Hessel, et al.Annals of Internal Medicine|March 1, 1986
Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarctionF Van de Werf, M Nobuhara, D CollenNature|December 31, 1997
Mice lacking factor VII develop normally but suffer fatal perinatal bleedingE D Rosen, J C Chan, E Idusogie, et al.Thrombosis Research|May 15, 1997
The inhibitory effect of heparin for vascular smooth muscle cell proliferation or migration is not mediated by u-PA and t-PAJ M Herbert, F Bono, I Lamarche, et al.Nature Medicine|September 5, 2001
Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndromeD Nuyens, M Stengl, S Dugarmaa, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery diseaseP Holvoet, J Van Cleemput, D Collen, et al.Pageof 64